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Biotransformation of 2-0-[l’J4C]hexadecylglycerol by photomixotrophic rape (Brassica naps) cells in sus- 
pension culture leads in appreciable yield (>60%) to l-acyl-2-O-[l’-14C]hexadecyl-sn-glycero-3-phospho- 
cholines. Alkaline hydrolysis of the acyl moiety in these phospholipids yields 2-0-[l’-iqC]hexadecyl-sn-glyce- 
ro-3-phosphocholine which is acetylated to l-acetyl-2-O-[l’-14C]hexadecyl-sn-glycero-3-phosphocholine, i.e. 
a positional isomer of platelet-activating factor. 
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1. INTRODUCTION 
Some physiologically active ether lipids are of 
great current interest in biomedical and clinical 
research [ 1,2]. These substances include platelet- 
activating factor (PAF), i.e. 2-acetyl-1-O-alkyl-sn- 
glycero-3-phosphocholines (I), a potent mediator 
of allergic reactions such as inflammation, asthma 
and anaphylaxis [1,3]. Numerous studies aimed at 
elucidating the role of PAF in the cell and at 
developing antagonists of this deleterious ether 
lipid are in progress [3,4]. The corresponding lyso 
compounds, i.e. 1-0-alkyl-sn-glycero-3-phos- 
phocholines (lyso-PAF), are used as antineoplastic 
agents [2]. 
Plant cells in culture are eminently useful for the 
semi-synthetic preparation of I as we reported 
recently [5-71. Here, we describe a procedure for 
the semi-synthesis of I-acetyl-2-0-[1 ‘-14C]alkyl- 
sn-glycero-3-phosphocholines (II) via the lyso 
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compound, two radiolabeled ether lipids, that may 
be helpful in a variety of biomedical investigations 
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2. MATERIALS AND METHODS 
2-O-[ 1’ -14C]Hexadecylglycerol (0.98 GBq/ 
mmol) was prepared from [l-‘4C]palmitic acid 
(Amersham Buchler, Braunschweig) by the reac- 
tion of the corresponding methanesulfonate with 
1,3-benzylideneglycerol f llowed by acid-catalyzed 
hydrolysis of the protecting group. The radio- 
chemical purity of the labeled 2-O-hexadecyl- 
glycerol was better than 98%. 
dylglycerophosphocholines isolated from rape cells 
was hydrolyzed with phospholipase C. The radio- 
activity of the resulting products, diradylglycerols 
and phosphocholine, was determined after TLC 
WI. 
For preparative purposes, 20 g rape cells were 
incubated with 370 kBq (380 nmol) 2-0- 
[l ‘-14C]hexadecylglycerol for 48 h, and the total 
lipids were isolated and fractionated by TLC as 
described above. 
Photomixotrophic cell suspension cultures of 
rape were propagated in modified MS medium [9]. 
The cultures were shaken under continuous il- 
lumination at 25°C and subcultured every lo-14 
days. The dry weight of the cells (900 mg dry 
material/l0 g cells fresh wt) was determined as in 
]51. 
Photomixotrophic rape cells, 2 g cells/4 ml 
preconditioned medium, were first incubated for 
1 h under anaerobic conditions (argon at- 
mosphere) and then added to 37 kBq (38 nmol) 
2-0-[l ‘-14C]hexadecylglycerol in 0.02 ml of 80% 
aqueous ethanol/diethyl ether (1: 2, v/v). The cells 
were incubated at 25°C for 4-48 h, under nearly 
anaerobic conditions. Aliquots of about 0.4 g rape 
cells each were withdrawn after 4, 8, 24, 36 and 
48 h of incubation. The cells were homogenized 
and the lipids extracted according to [lo]. The 
radioactivity of the extracts was determined by li- 
quid scintillation counting of aliquots. 
1-Acyl-2-0-[1 ‘-‘4C]hexadecyl-sn-glycero-3-phos- 
phocholines (100 kBq) isolated from rape cells 
were subjected to alkaline hydrolysis. The result- 
ing 2-0-[l ‘-14C]hexadecyl-sn-glycero-3- phospho- 
choline (analogue of lyso-PAF; 95% yield based 
on labeled 1-acyl-2-O-hexadecyl-sn-glycero- 3- 
phosphocholines) (Rf 0.23) was purified by TLC 
on silica gel with chloroform/methanol/water 
(70:35:7, by vol.), isolated, and acetylated [5]. 
The final product, 1-acetyl-2-0-[1 ‘-14C]hexadecyl- 
sn-glycero-3-phosphocholine (analogue of PAF; 
95% yield based on the lyso compound) (Rf 0.22) 
was purified by TLC on silica gel using chloro- 
form/methanol/water/acetic acid (70: 35 : 5 : 5, by 
vol.). 
The total lipids extracted from the incubation 
mixtures were fractionated by TLC on silica gel 
with chloroform/methanol/water (65 : 25 : 4, by 
vol.), and the distribution of radioactivity in the 
various fractions was determined by scanning. The 
fractions of diradylglycerophosphocholines (Rf 
0.25) and neutral lipids (Rr 0.8-1.0) were each 
isolated. The neutral lipids were further resolved 
by TLC on silica gel with hexane/diethyl ether 
(7 : 3, v/v), twice, and the radioactivity in the frac- 
tions of diradylglycerols (Rf 0.20-0.30) and 
triradylglycerols (Rf 0.80) was determined by scan- 
ning. The radioactive lipid fractions were purified 
and characterized as described [6]. 
The purity of II was checked by co- 
chromatography with a standard on silica gel 
layers with chloroform/methanol/ammonia 
(70:35:7, by vol.) as well as by two-dimensional 
TLC on silica gel using chloroform/methanol/ 
water (65 : 35 : 7, by vol.) in the first dimension and 
chloroform/methanol/ammonia (65:35:7, by 
vol.) in the second. Radioactivity was detected by 
scanning and evaluated using a perspective TLC 
program (BF-Vertriebsgesellschaft, Wildbad, 
FRG). Aliquots of the labeled product were re- 
duced with lithium aluminium hydride, subjected 
to alkaline hydrolysis or hydrolyzed with 
phospholipase C, and the reaction products 
analyzed and characterized as described above. 
3. RESULTS AND DISCUSSION 
Aliquots of the fractions of diradylglycero- Higher plants do not contain appreciable 
phosphocholines, diradylglycerols and triradylgly- amounts of ether lipids, if any [ll]. Yet, 
cerols were reduced with lithium aluminium photomixotrophic rape cells in suspension culture 
hydride. The resulting radioactive long-chain transform exogenous 2-O-[ 1’ -r4C]hexadecylgly- 
alcohols and hexadecylglycerol were analyzed and cerol to I-acyl-2-O-[ 1’ -14C]hexadecyl-sn-glycero- 
characterized [6]. An aliquot of labeled dira- 3-phosphocholines, l(3)-acyl-2-O-[ 1’ -14C]hexade- 
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cylglycerols and 1,3-diacyl-2-0-[1 ‘-‘4C]hexade- 
cylglycerols . 
The cells readily take up the radioactive precur- 
sor from the incubation medium (>97% within 
4 h). The time course of biotr~sformation of 2-O- 
[ 1’ -‘4C)hexadecylgIycerol ver a period of 48 h is 
shown in fig. 1. The radioactive substrate is incor- 
porated predominantly into diradylglycerophos- 
phocholines. After 48 h, more than 5070 of the 
radioactivity is found in these ionic ether lipids, 
whereas other radiolabeled polar lipids amount to 
around 3% only. Neutral ether glycerolipids, 1(3)- 
acyl-2-0-hexadecylglycerols and 1,3-diacyl-2-0- 
hexadecyl~ycerols contain about 20 and 10010, 
respectively, of the total radioactivity. 
The radioactive acyl moieties of lipids that had 
been isolated from rape cells were analyzed after 
reduction with lithium ahtminium hydride. It was 
found that at m~imum 3% of the radioactivity 
was located in Iong-chain alcohols derived from 
acyl moieties of diradylglycerophosphocholines, 
diradylglycerols and triradylglycerols. Obviously, 
under the conditions described only small propor- 
tions of the radioactive substrate were degraded by 
Time(h) 
Fig. I. Incorporation of radioactivity from 2-G 
[ 1’ -‘4C]hexadecylgiycerol into ether lipids of rape cells 
in suspension culture as well as the decrease of 
radioactive substrate during incubation (M, 2-O- 
[ 1 ‘-‘4C]hexadecylglyceroi, substrate; ti , diradyl- 
glycerols; p---v , triradylglycero~s; D--II , diradyl- 
glycerophosphocholines; m, other polar lipids). 
oxidative cleavage, even after 48 h of incubation. 
This finding was confirmed by the results of an 
analysis of the products obtained by alkaline 
hydrolysis of radioactive diradylglycerophospho- 
cholines. Radioactive compounds formed by oxi- 
dation of the substrate were not detected in the 
phosphocholine moiety of diradylglycerophospho- 
cholines liberated by enzymatic cleavage at the 
phosphodiester linkage with phospholipase 6. 
Recently, we observed that cholinephospho- 
transferase of cultured plant cells esterifies phos- 
phocholine moieties to 1,2-diradyl-sn-glycerols 
with high stereospecificity, whereas the corre- 
sponding enantiomers, i.e. 2,3-diradyl-sn-glyc- 
erols, are not utilized as substrates at all 171. The 
chiral purity of 1 -acyI-2-O-hexadecyl-sn-glycero-3- 
phosphocholines, prepared by biotransformation 
from 2-0-hexadecylglycerol using rape cell 
cultures, was checked by determination of the op- 
tical rotation of derivatives, as described in [SJ. 
The chemical synthesis of 2-O-alkyl-l-radyl-sn- 
glycero-3-phosphocholines tarts from optically 
active glycerol derivatives [ 121. Syntheses using 
2-O-alkylgly~erols as starting material lead to 
racemic mixtures. Separation of the two enan- 
tiomers is difficult and lowers the yield of the 
desired stereoisomer having the ‘natural’ con- 
figuration. We have prepared such an analogue of 
PAF containing a 2-O+ ‘-‘4C]hexadecyl moiety 
by incubation of rape cells with radioactive 2-0- 
hexadecylglycerol. This semi-synthesis leads in 
remarkably high yield (overall yield 42%) to 
I-acyl-2-0-[1 ‘-‘4C]hexadecyl-sn-glycero-3-phos- 
phochoIines; the method does not require the 
separation of enantiomers. The radioactive sub- 
strate incorporated into alkylacylglycerols and 
alkyldiacylglycerols can be easily recovered after 
alkaline hydrolysis and recycled together with the 
unmetabolized substrate in further incubations to 
increase the overall yield; an additional IO-15% of 
l-acyl-2-O-[l’-‘4C]hexadecyl-sn-glycero-3-phos- 
phocholines are thus obtained. 
Alkaline hydrolysis of radioactive diradylglyc- 
erophospho~holines followed by acetylation of the 
resulting lyso ether lipid leads to I-acetyl-2-0- 
[l ‘-14C]hexadecyl-sn-glycero-3-phosphocholine in 
an overall yield of about 50% (with respect to 
[l-*4C]paImitic acid used). The specific activity 
(0.98 GBq/mmol) of the added precursor and the 
resulting metabolites is the same because these 
227 
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plant cells do not contain ether lipids. The 
radiochemical purity of the isolated PAF analogue 
II was better than 98%. 
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